Toward an understanding of tissue factor pathway inhibitor‐2 as a novel serodiagnostic marker for clear cell carcinoma of the ovary
Author:
Affiliation:
1. Department of Obstetrics and Gynecology Nara Medical University Kashihara Nara Japan
2. Ms. Clinic MayOne Kashihara Nara Japan
Funder
Japan Society for the Promotion of Science
Publisher
Wiley
Subject
Obstetrics and Gynecology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jog.14916
Reference97 articles.
1. Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
2. Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma
3. Secretome-Based Identification of TFPI2, A Novel Serum Biomarker for Detection of Ovarian Clear Cell Adenocarcinoma
4. cDNA Cloning and mRNA Expression of a Serine Proteinase Inhibitor Secreted by Cancer Cells: Identification as Placental Protein 5 and Tissue Factor Pathway Inhibitor-2
5. Extracellular Matrix-Associated Serine Protease Inhibitors (Mr33,000, 31,000, and 27,000) Are Single-Gene Products with Differential Glycosylation: cDNA Cloning of the 33-kDa Inhibitor Reveals Its Identity to Tissue Factor Pathway Inhibitor-2
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer;International Journal of Molecular Sciences;2024-09-13
2. Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study;BMC Cancer;2024-08-27
3. Tissue factor pathway inhibitor-2 (TFPI-2)—an underappreciated partaker in cancer and metastasis;Cancer and Metastasis Reviews;2024-08-17
4. Dual Role of Tissue Factor Pathway Inhibitor 2—A Novel Serodiagnostic Marker for Ovarian Cancer—In Human Cancers;International Journal of Translational Medicine;2024-06-28
5. Long Non-Coding RNAs: Bridging Cancer-Associated Thrombosis and Clinical Outcome of Ovarian Cancer Patients;International Journal of Molecular Sciences;2023-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3